Abstract

Calcium/Calcineurin/Nuclear Factor of Activated T cells (Ca/CN/NFAT) signalling pathway is the main calcium (Ca2+) dependent signalling pathway involved in the homeostasis of brain tissue. Here, we study the presence of NFATc members in human glioma by using U251 cells and a collection of primary human glioblastoma (hGB) cell lines. We show that NFATc3 member is the predominant member. Furthermore, by using constitutive active NFATc3 mutant and shRNA lentiviral vectors to achieve specific silencing of this NFATc member, we describe cytokines and molecules regulated by this pathway which are required for the normal biology of cancer cells. Implanting U251 in an orthotopic intracranial assay, we show that specific NFATc3 silencing has a role in tumour growth. In addition NFATc3 knock-down affects both the proliferation and migration capacities of glioma cells in vitro. Our data open the possibility of NFATc3 as a target for the treatment of glioma.

Details

Title
NFATc3 controls tumour growth by regulating proliferation and migration of human astroglioma cells
Author
Urso, Katia 1 ; Fernández, Andrés 2 ; Velasco, Patricia 2 ; Cotrina, Javier 2 ; Belén de Andrés 3 ; Sánchez-Gómez, Pilar 2   VIAFID ORCID Logo  ; Hernández-Laín, Aurelio 4 ; Hortelano, Sonsoles 5 ; Juan Miguel Redondo 1   VIAFID ORCID Logo  ; Cano, Eva 2   VIAFID ORCID Logo 

 Department of Vascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain 
 Chronic Disease Programme, Madrid, Spain 
 Centro Nacional de Microbiología, Madrid, Spain 
 Hospital Doce de Octubre, Madrid, Spain 
 Instituto de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain 
Pages
1-14
Publication year
2019
Publication date
Jun 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2248352549
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.